Full history for every metric is available with a Kvantra account
Instem plc (INS.L)
Key financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 22 | 23 | 26 | 28 | 46 | 59 | 61 |
| Operating profit | £m | 7 | 6 | |||||
| Net profit | £m | 1 | 1 | -1 | 2 | 2 | 5 | 3 |
| EPS reported | £ | 0.20 | 0.14 | |||||
| Operating cashflow per share | £ | 0.35 | 0.35 | |||||
| Capex per share | £ | 0.16 | 0.16 | |||||
| FCF per share | £ | 0.19 | 0.19 | |||||
| Free cash flow | £m | 4 | 8 | |||||
| Net debt | £m | -14 | -8 | |||||
| Book value equity | £m | 53 | 55 | |||||
| Book value per share | £ | 2.25 | 2.40 | |||||
| Number of shares | m | 23.69 | 22.8 | |||||
| DPS (TTM paid) | £ | 0.00 | 0.00 |
Financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 35.50 | - | |||||
| P/B LTM | x | 3.00 | 3.65 | |||||
| P/S LTM | x | 2.72 | 3.27 | |||||
| P/FCF LTM | x | 36.78 | 24.89 | |||||
| EV/EBITDA LTM | x | 13.64 | 21.50 | |||||
| EV/Sales LTM | x | 2.51 | 3.14 | |||||
| Earnings Yield LTM | % | 2.82% | 2.51% | |||||
| FCF Yield | % | 2.72% | 4.02% | |||||
| Quality | ||||||||
| ROE | % | 8.80% | 9.33% | |||||
| ROIC | % | 10.58% | 10.58% | |||||
| Operating margin | % | 12.27% | 12.27% | |||||
| Gross margin | % | 41.51% | 41.51% | |||||
| FCF/Sales | % | 7.40% | 7.40% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +170.27% | - | |||||
| Sales Growth YoY | % | +27.95% | - | |||||
| Net Income Growth YoY | % | +179.92% | - | |||||
| FCF Growth | % | -36.08% | - | |||||
| Operating Profit Growth | % | +55.22% | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 3.34 | 4.22 | |||||
| Net Debt/EBITDA | x | -1.17 | -1.17 | |||||
| EBIT/Net interest | x | 6.32 | 6.32 | |||||
| Net debt/market cap | % | -8.71% | -3.83% | |||||
| Net debt/Equity | x | -0.26 | -0.14 | |||||
| Gross debt/equity | x | 0.02 | 0.03 | |||||
Company overview
Established in 1969 and based in Stone, United Kingdom, Instem plc provides information technology applications to the global life sciences and healthcare sectors. The company's core mission is to equip organizations with robust solutions for data capture, management, and analysis, thereby facilitating informed, data-driven decision-making processes. Instem's extensive suite of offerings addresses diverse needs across research and development. For early-phase clinical trials, it offers ALPHADAS, an eSource system. Discovery research is supported by tools like BioRails for data management and Morphit for data visualization. The portfolio also includes computational toxicology products and services, alongside Provantis, a Windows-based system for non-clinical evaluation studies. Specialized solutions comprise Comet Assay IV, a live video imaging system for reproducible comet slide scoring, and Cyto Study Manager for cytology data acquisition and reporting. Furthermore, NOTOCORD-hem software platforms are available for acquiring, displaying, and analyzing physiological signals. A significant area of focus is regulatory information management. Instem provides Samarind RMS for managing medical product information and a comprehensive set of tools for the Standard for Exchange of Nonclinical Data (SEND). This includes the submit platform for creating and managing SEND datasets, SENDView for reviewing them, SEND Explorer for web-based access with optional data warehousing, and SENDTrial, a subscription-based web solution. Other offerings include Logbook, an information repository, and the Sorcerer Colony Counter for automatic plate counting. Beyond its software products, Instem delivers a broad range of services such as sales support, training, validation, consultancy, and cloud services, in addition to safety assessment and regulatory information management software. The company also develops, manufactures, and supplies both software and hardware specifically for in vitro study data collection and management, enabling intelligence extraction from R&D related healthcare data.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Instem plc (INS.L)
Established in 1969 and based in Stone, United Kingdom, Instem plc provides information technology applications to the global life sciences and healthcare sectors. The company's core mission is to equip organizations with robust solutions for data capture, management, and analysis, thereby facilitating informed, data-driven decision-making processes. Instem's extensive suite of offerings addresses diverse needs across research and development. For early-phase clinical trials, it offers ALPHADAS, an eSource system. Discovery research is supported by tools like BioRails for data management and Morphit for data visualization. The portfolio also includes computational toxicology products and services, alongside Provantis, a Windows-based system for non-clinical evaluation studies. Specialized solutions comprise Comet Assay IV, a live video imaging system for reproducible comet slide scoring, and Cyto Study Manager for cytology data acquisition and reporting. Furthermore, NOTOCORD-hem software platforms are available for acquiring, displaying, and analyzing physiological signals. A significant area of focus is regulatory information management. Instem provides Samarind RMS for managing medical product information and a comprehensive set of tools for the Standard for Exchange of Nonclinical Data (SEND). This includes the submit platform for creating and managing SEND datasets, SENDView for reviewing them, SEND Explorer for web-based access with optional data warehousing, and SENDTrial, a subscription-based web solution. Other offerings include Logbook, an information repository, and the Sorcerer Colony Counter for automatic plate counting. Beyond its software products, Instem delivers a broad range of services such as sales support, training, validation, consultancy, and cloud services, in addition to safety assessment and regulatory information management software. The company also develops, manufactures, and supplies both software and hardware specifically for in vitro study data collection and management, enabling intelligence extraction from R&D related healthcare data.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free